Chembio diagnostics appoints david acheson, m.d. to its board of directors

Hauppauge, n.y., dec. 17, 2020 (globe newswire) -- chembio diagnostics, inc. (nasdaq: cemi), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of david acheson, m.d. to the company's board of directors.
CEMI Ratings Summary
CEMI Quant Ranking